NewcelX Ltd. NCEL
2.86 USD +0.08 (+2.88%)
At closeNov 10, 2026, 4:50 PM EST
2.92 +0.06 +2.10%
After hours · Nov 10, 4:50 PM ET
2.68 Day range 2.89
1.88 52-week range 4.91
- YTD
- +50.53%
- 1 year
- -26.48%
- Market cap
- 16.52M
- EPS (ttm)
- 0.52
- P/E ratio
- 5.50
- YTD return
- +50.53%
- 1-year return
- -26.48%
- Volume
- 24.39K
- Avg volume
- 13.41K
- Open
- 2.86
- Previous close
- 2.78
- Day's range
- 2.68 – 2.89
- 52-week range
- 1.88 – 4.91
5D +0.38 (+15.83%)
Financials — quick view
NCEL Revenue — annual 0
NCEL Net income — annual -8.30M
NCEL EPS — annual -2.16
News
CORRECTION: NewcelX Announces $1.55M Private Placement Of 471,125 Common Shares And One Series Of Warrants At A Price Of $3.29 Per Share 
NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes 
12 Health Care Stocks Moving In Thursday's Pre-Market Session - 12 Health Care Stocks Moving In Friday's Pre-Market Session
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing 
NewcelX Issued Patent From Brazilian Patent And Trademark Office For Its Nnovative Cell Selection And Enrichment Technology
Your note
Sign in to keep a note on NCEL — it syncs with the Stock Master app.